News
Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...
Trump's plan to lower Medicare drug costs by aligning U.S. prices with other countries faces legal and industry challenges.
It’s unclear what — if any — impact the Republican president’s executive order will have on millions of Americans who have ...
Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...
The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible ...
UnitedHealth Group will stop compensative brokers and sales agents who sell new Medicare Part D prescription drug plans.
CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public ...
Medicare announced an additional batch of 15 drugs subject to negotiation for discounts beginning in 2027. The law also called for penalties on drug companies that raised prices on ...
When Congress adopted the Inflation Reduction Act (IRA) in 2022, creating the Medicare Drug Price Negotiation Program (MDPNP), the bill did ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback